Researchers at Oregon Health & Science University’s School of Dentistry have made an important connection between a molecule critical to nerve cells and high blood pressure. Production of the molecule Brain-Derived Neurotrophic Factor (BDNF) appears ...
A promising cancer pill could provide a treatment option for leukemia patients whose disease no longer responds to currently available drugs. Ponatinib, which was developed by ARIAD Pharmaceuticals Inc. in a research collaboration with the Knight ...
Oregon Health & Science University will receive Phase II funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables individuals worldwide to test bold ideas to address persistent health and ...
Oregon Health & Science University's development of a new gene therapy method to prevent certain inherited diseases has reached a significant milestone. Researchers at the university's Oregon National Primate Research Center and the OHSU Department of ...
Tomasz Beer, M.D., deputy director of the Knight Cancer Institute at Oregon Health & Science University (OHSU), was selected as one of six top scientists to take part in a research Dream Team that joins together world-class institutions to study ...
The Oregon National Primate Research Center at Oregon Health & Science University has received another clean bill of health from the United States Department of Agriculture. Approximately twice a year, a USDA animal care expert conducts an ...
Researchers at Oregon Health & Science University (OHSU) have developed a technique that, similar to a carnival barker at the circus, can determine weight based on appearance. Today, an article outlining the technique was published in the Physical ...
Many people with multiple sclerosis for years have taken the natural supplement Gingko biloba, believing it helps them with cognitive problems associated with the disease. But the science now says otherwise. A new study published in the journal ...
A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal ...
For decades, a successful HIV vaccine has been the Holy Grail for researchers around the globe. Yet despite years of research and millions of dollars of investment, that goal has still yet to be achieved. Recent research by Oregon Health & Science ...